Haisco Pharmaceutical Group Co., Ltd. at its 2nd Extraordinary General Meeting of 2023 on 25 August 2023, during which the following proposal(s) was/were approved: Election and nomination of non-independent directors, cumulative voting system applicable: Wang Junmin, Fan Xiulian, Zheng Wei, Yan Pangke. Election and nomination of independent directors, cumulative voting system applicable: Yue Lin and Cao Chuande. Election of shareholder supervisors, cumulative voting system applicable: Liang Yuan and Sun Tao.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.2 CNY | -1.40% | -3.36% | +30.45% |
04-19 | Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
04-18 | Haisco Pharmaceutical Gets Nod to Trial HSK16149 Capsules | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.45% | 4.61B | |
+29.98% | 682B | |
+30.54% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.74% | 240B | |
+9.71% | 209B | |
-8.55% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 002653 Stock
- News Haisco Pharmaceutical Group Co., Ltd.
- Haisco Pharmaceutical Group Co., Ltd. Announces Management Changes